NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of
ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 3 3% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $15.38 and last traded at $15.46, with a volume of 11991 shares trading hands. The stock had previously closed at $16.04. Wall Street Analysts Forecast Growth A number of […]
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $15.38 and last traded at $15.46, with a volume of 11991 shares trading hands. The stock had previously closed at $16.04. Wall Street Analysts Forecast Growth A number of […]
Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) saw strong trading volume on Monday . 190,786 shares were traded during trading, a decline of 12% from the previous session’s volume of 216,591 shares.The stock last traded at $18.25 and had previously closed at $17.86. Analyst Upgrades and Downgrades A number of equities research […]